Stealth needle

Reference number
Coordinator SAGA SURGICAL AB
Funding from Vinnova SEK 998 000
Project duration June 2018 - October 2019
Status Ongoing
Venture Swelife and Medtech4Health- Project proposals to improve health
Call Förbättrad prevention, diagnos och behandling – Swelife och Medtech4health

Purpose and goal

Saga Surgical develops a method that will significantly reduce the risk of sepsis in the diagnosis of prostate cancer by biopsy.

Expected results and effects

First and foremost it leads to higher patient safety, but it also contributes to significantly reduced healthcare costs and decreased use of antibiotics.

Planned approach and implementation

The method will be tested on humans, first in a pilot study together with Region Skåne. The next step is to do a larger human study with more participating clinics from both Sweden and abroad. Vinnova contributes with funding for the pilot study and the preparations required to get CE-label to be approved for the larger study.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.